z-logo
open-access-imgOpen Access
In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor
Author(s) -
Hongjie Wang,
Chang Li,
Adebimpe Obadan,
Hannah Frizzell,
Tien-Ying Hsiang,
Sucheol Gil,
Audrey Germond,
Connie Fountain,
Audrey Baldessari,
Steve R. Roffler,
HansPeter Kiem,
Deborah H. Fuller,
André Lieber
Publication year - 2022
Publication title -
human gene therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.633
H-Index - 149
eISSN - 1557-7422
pISSN - 1043-0342
DOI - 10.1089/hum.2021.295
Subject(s) - genetic enhancement , haematopoiesis , biology , stem cell , immunology , in vivo , hematopoietic stem cell , bone marrow , cytokine , viremia , transgene , transduction (biophysics) , viral vector , severe combined immunodeficiency , cancer research , microbiology and biotechnology , virus , gene , recombinant dna , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom